ITGAM and neoplasm: Given that the immunosuppressive myeloid cell compartment is significantly diminished systemically within 24 h after GEM treatment, we hypothesized that GEM aids in constraining TNBC outgrowth and significantly lengthens the overall survival time of tumor-bearing mice by depleting Ly6G+CD11b+ G-MDSCs in the TME (Figure S5).